Citation:Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC 2018

From Cancer Guidelines Wiki

Citation


Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018 Jan;51(1):77-86 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29055060.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Ovarian suppression during chemotherapyDr Wanyuan Cui MBBS BMEDSCI FRACPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Ovarian suppression with GnRH analogues